![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Switch to Elvitegravir/Cobi/FTC/TDF from PI+RTV or NNRTI plus
FTC/TDF Maintains HIV Suppression at Week 48 and is Safe in Black Subjects
|
|
|
Reported by Jules Levin
ICAAC 2014 Sept 5-9 Wash DC
J Gathe1, S Lewis2, W Jordon3, J Arribas4, A Pozniak5, L Dau6, W Garner6, T Nguyen6, B Guyer6
1Therapeutic Concepts, Houston, TX; 2ST. HOPE Foundation, Houston, TX; 3Charles R Drew Univ. and MLK Ambulatory Care OASIS Clinic, Los Angeles, CA;
4Hospital Universitario La Paz, Madrid, Spain; 5Chelsea and Westminster Hospital, London, UK; 6Gilead Sciences, Inc., Foster City, CA
![ICAAC1.gif](../images/090814/090814-3/ICAAC1.gif)
![ICAAC2.gif](../images/090814/090814-3/ICAAC2.gif)
![ICAAC3.gif](../images/090814/090814-3/ICAAC3.gif)
![ICAAC4.gif](../images/090814/090814-3/ICAAC4.gif)
![ICAAC5.gif](../images/090814/090814-3/ICAAC5.gif)
![ICAAC6.gif](../images/090814/090814-3/ICAAC6.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|